Tiago Biachi, MD, PhD, emphasizes that biosimilars are vital for reducing financial toxicity and ensuring equitable, affordable access to advanced treatments in gastrointestinal (GI) cancer care, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback